Campath and Aranesp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Campath (alemtuzumab) and Aranesp (darbepoetin alfa). Common drug interactions include chills among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Campath and Aranesp. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.

On Jul, 08, 2026

44 people who take Campath and Aranesp together, and have interactions are studied.

What are the common drug interactions of Campath and Aranesp, by gender? *:

female:

Chills (felling of cold)
Nausea (feeling of having an urge to vomit)
Pain
Pyrexia (fever)
Ureteric stenosis (abnormal narrowing or contraction of a duct or canal)

male:

Renal failure acute (rapid kidney dysfunction)
Pyrexia (fever)
Haemorrhage (bleeding)
Multi-organ failure (multisystem organ failure)
Febrile neutropenia (fever with reduced white blood cells)
Hepatic failure (liver failure)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Campath and Aranesp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chills (felling of cold)
Nausea (feeling of having an urge to vomit)
Pain
Pyrexia (fever)
Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
Arteriovenous fistula aneurysm (destruction of the vessel wall and replacement by biophysically inferior collagenous tissue)
Complications of transplanted kidney
Diarrhoea
Dyspepsia (indigestion)
Hepatosplenomegaly (enlargement of both the liver and the spleen)

40-49:

Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pyrexia (fever)

50-59:

Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Multi-organ failure (multisystem organ failure)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Respiratory failure (inadequate gas exchange by the respiratory system)
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Anaemia (lack of blood)
Reticulocyte count decreased
Bacteraemia (presence of bacteria in the blood)

60+:

Renal failure acute (rapid kidney dysfunction)
Acute respiratory distress syndrome
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pyrexia (fever)
Splenic abscess (pus in spleen or near by)
Hepatomegaly (abnormal enlargement of the liver)
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Platelet count decreased
Thrombocytopenia (decrease of platelets in blood)

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 10 people, 22.73%
Anaemia (lack of blood): 8 people, 18.18%
Glaucoma (increased fluid pressure in the eye with vision loss): 7 people, 15.91%
Diabetes: 7 people, 15.91%
Pain: 7 people, 15.91%
High Blood Pressure: 7 people, 15.91%
Constipation: 7 people, 15.91%
Leukopenia (less number of white blood cells in blood): 5 people, 11.36%
Stress And Anxiety: 5 people, 11.36%
Anaemia Postoperative: 4 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Campath and Aranesp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously